Point72 Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,988,421
| Closed | -$6.64M | – | 1575 |
|
|
2024
Q4 | $6.64M | Buy |
8,988,421
+7,758,371
| +631% | +$5.73M | 0.01% | 629 |
|
|
2024
Q3 | $1.93M | Sell |
1,230,050
-2,891,141
| -70% | -$4.54M | ﹤0.01% | 749 |
|
|
2024
Q2 | $6.92M | Buy |
4,121,191
+3,536,805
| +605% | +$5.94M | 0.02% | 574 |
|
|
2024
Q1 | $1.4M | Buy |
+584,386
| New | +$1.4M | ﹤0.01% | 904 |
|
|
2023
Q2 | – | Sell |
-516,367
| Closed | -$1.25M | – | 1936 |
|
|
2023
Q1 | $1.25M | Sell |
516,367
-827,764
| -62% | -$2.01M | ﹤0.01% | 853 |
|
|
2022
Q4 | $2.57M | Sell |
1,344,131
-2,269,369
| -63% | -$4.33M | 0.01% | 728 |
|
|
2022
Q3 | $8.67M | Buy |
+3,613,500
| New | +$8.67M | 0.03% | 505 |
|
|
2019
Q4 | – | Sell |
-528,100
| Closed | -$1.59M | – | 1069 |
|
|
2019
Q3 | $1.59M | Buy |
+528,100
| New | +$1.59M | 0.01% | 568 |
|
|
2017
Q2 | – | Sell |
-382,500
| Closed | -$5.49M | – | 815 |
|
|
2017
Q1 | $5.49M | Buy |
+382,500
| New | +$5.49M | 0.03% | 464 |
|